FR2179899A1 - - Google Patents

Info

Publication number
FR2179899A1
FR2179899A1 FR7312823A FR7312823A FR2179899A1 FR 2179899 A1 FR2179899 A1 FR 2179899A1 FR 7312823 A FR7312823 A FR 7312823A FR 7312823 A FR7312823 A FR 7312823A FR 2179899 A1 FR2179899 A1 FR 2179899A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7312823A
Other languages
French (fr)
Other versions
FR2179899B1 (US20080094685A1-20080424-C00004.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2179899A1 publication Critical patent/FR2179899A1/fr
Application granted granted Critical
Publication of FR2179899B1 publication Critical patent/FR2179899B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/148Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5052Proteins, e.g. albumin
    • A61K9/5057Gelatin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D1/00Evaporating
    • B01D1/16Evaporating by spraying
    • B01D1/18Evaporating by spraying to obtain dry solids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
FR7312823A 1972-04-10 1973-04-10 Expired FR2179899B1 (US20080094685A1-20080424-C00004.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24278972A 1972-04-10 1972-04-10

Publications (2)

Publication Number Publication Date
FR2179899A1 true FR2179899A1 (US20080094685A1-20080424-C00004.png) 1973-11-23
FR2179899B1 FR2179899B1 (US20080094685A1-20080424-C00004.png) 1976-09-10

Family

ID=22916188

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7312823A Expired FR2179899B1 (US20080094685A1-20080424-C00004.png) 1972-04-10 1973-04-10

Country Status (8)

Country Link
JP (1) JPS5418331B2 (US20080094685A1-20080424-C00004.png)
AT (1) AT353232B (US20080094685A1-20080424-C00004.png)
BE (1) BE797921A (US20080094685A1-20080424-C00004.png)
CH (1) CH586568A5 (US20080094685A1-20080424-C00004.png)
DE (1) DE2317434A1 (US20080094685A1-20080424-C00004.png)
FR (1) FR2179899B1 (US20080094685A1-20080424-C00004.png)
GB (1) GB1422974A (US20080094685A1-20080424-C00004.png)
NL (1) NL7304921A (US20080094685A1-20080424-C00004.png)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58154547A (ja) * 1982-03-09 1983-09-14 Nippon Shinyaku Co Ltd アズレン誘導体の安定化法
JP2546838B2 (ja) * 1986-03-24 1996-10-23 エフ・ホフマン―ラ ロシユ アーゲー ビタミン製剤の製造方法
JP3555640B2 (ja) * 1996-05-10 2004-08-18 ライオン株式会社 天然カロチノイドを包含した多芯型構造のマイクロカプセル並びに錠剤、食品用及び医薬品用配合剤
CA2339991C (en) * 1998-08-13 2007-01-02 Cima Labs Inc. Microemulsions as solid dosage forms for oral administration
JP2000086537A (ja) * 1998-09-11 2000-03-28 Fuji Chem Ind Co Ltd 無機化合物糖類組成物、賦形剤、速崩壊性圧縮成型物及びその製造方法
JP5684440B2 (ja) * 2001-02-23 2015-03-11 シーマ・ラブス、インコーポレイテッド 組成物および固形製剤
US8080172B2 (en) 2006-01-18 2011-12-20 J.I. Enterprises, Inc. Method and composition for controlled heat release and disposable chemical heater utilizing same
LT2487162T (lt) 2007-02-23 2016-11-10 Gilead Sciences, Inc. Terapinių agentų farmakokinetinių savybių moduliatoriai
US20080254119A1 (en) * 2007-04-16 2008-10-16 Wyeth Imbedded liquid lubricants for tableting
US10039718B2 (en) 2008-05-02 2018-08-07 Gilead Sciences, Inc. Use of solid carrier particles to improve the processability of a pharmaceutical agent
ES2684327T5 (es) * 2010-12-27 2022-03-01 Dsm Ip Assets Bv Formulaciones de vitamina E en polvo

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1266902A (fr) * 1960-09-06 1961-07-17 Procédé de production de préparations stables de vitamines
FR1546920A (fr) * 1966-12-02 1968-11-22 Niro Atomizer As Roue d'atomisation simultanée de deux composants
US3608083A (en) * 1968-06-05 1971-09-21 Hoffmann La Roche Vitamin e powder

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1266902A (fr) * 1960-09-06 1961-07-17 Procédé de production de préparations stables de vitamines
FR1546920A (fr) * 1966-12-02 1968-11-22 Niro Atomizer As Roue d'atomisation simultanée de deux composants
US3608083A (en) * 1968-06-05 1971-09-21 Hoffmann La Roche Vitamin e powder

Also Published As

Publication number Publication date
FR2179899B1 (US20080094685A1-20080424-C00004.png) 1976-09-10
GB1422974A (en) 1976-01-28
DE2317434A1 (de) 1973-12-06
JPS497415A (US20080094685A1-20080424-C00004.png) 1974-01-23
AT353232B (de) 1979-11-12
NL7304921A (US20080094685A1-20080424-C00004.png) 1973-10-12
CH586568A5 (US20080094685A1-20080424-C00004.png) 1977-04-15
BE797921A (fr) 1973-10-09
ATA310873A (de) 1979-04-15
JPS5418331B2 (US20080094685A1-20080424-C00004.png) 1979-07-06

Similar Documents

Publication Publication Date Title
JPS4956763U (US20080094685A1-20080424-C00004.png)
CH573976A5 (US20080094685A1-20080424-C00004.png)
BG17145A1 (US20080094685A1-20080424-C00004.png)
BG17676A1 (US20080094685A1-20080424-C00004.png)
BG18781A1 (US20080094685A1-20080424-C00004.png)
BG20645A1 (US20080094685A1-20080424-C00004.png)
CH441173A4 (US20080094685A1-20080424-C00004.png)
CH559489A5 (US20080094685A1-20080424-C00004.png)
CH559550A5 (US20080094685A1-20080424-C00004.png)
CH559598A5 (US20080094685A1-20080424-C00004.png)
CH560870A5 (US20080094685A1-20080424-C00004.png)
CH561486A5 (US20080094685A1-20080424-C00004.png)
CH562334A5 (US20080094685A1-20080424-C00004.png)
CH563766A5 (US20080094685A1-20080424-C00004.png)
CH564948A5 (US20080094685A1-20080424-C00004.png)
CH565246A5 (US20080094685A1-20080424-C00004.png)
CH565301A5 (US20080094685A1-20080424-C00004.png)
CH565321A5 (US20080094685A1-20080424-C00004.png)
CH565885A5 (US20080094685A1-20080424-C00004.png)
CH566060A5 (US20080094685A1-20080424-C00004.png)
CH566566A5 (US20080094685A1-20080424-C00004.png)
CH566631A5 (US20080094685A1-20080424-C00004.png)
CH567003A5 (US20080094685A1-20080424-C00004.png)
CH567700A5 (US20080094685A1-20080424-C00004.png)
CH569171A5 (US20080094685A1-20080424-C00004.png)

Legal Events

Date Code Title Description
ST Notification of lapse